Similar articles for PMID: 31253745

Year	Number of Results
2007	1
2008	2
2010	3
2011	7
2012	11
2013	13
2014	19
2015	21
2016	29
2017	24
2018	26
2019	33
2020	61
2021	57
2022	41
2023	13
2024	0

1

Multiparametric ¹⁸F-FDG PET/MRI of the Breast: Are There Differences in Imaging Biomarkers of Contralateral Healthy Tissue Between Patients With and Without Breast Cancer?

Leithner D, Helbich TH, Bernard-Davila B, Marino MA, Avendano D, Martinez DF, Jochelson MS, Kapetas P, Baltzer PAT, Haug A, Hacker M, Tanyildizi Y, Morris EA, Pinker K. Leithner D, et al. J Nucl Med. 2020 Jan;61(1):20-25. doi: 10.2967/jnumed.119.230003. Epub 2019 Jun 28. J Nucl Med. 2020. PMID: 31253745 Free PMC article.

2

A multiparametric [¹⁸F]FDG PET/MRI diagnostic model including imaging biomarkers of the tumor and contralateral healthy breast tissue aids breast cancer diagnosis.

Leithner D, Horvat JV, Bernard-Davila B, Helbich TH, Ochoa-Albiztegui RE, Martinez DF, Zhang M, Thakur SB, Wengert GJ, Staudenherz A, Jochelson MS, Morris EA, Baltzer PAT, Clauser P, Kapetas P, Pinker K. Leithner D, et al. Eur J Nucl Med Mol Imaging. 2019 Aug;46(9):1878-1888. doi: 10.1007/s00259-019-04331-6. Epub 2019 Jun 13. Eur J Nucl Med Mol Imaging. 2019. PMID: 31197455 Free PMC article. Clinical Trial.

3

Quantitative Assessment of Breast Parenchymal Uptake on 18F-FDG PET/CT: Correlation with Age, Background Parenchymal Enhancement, and Amount of Fibroglandular Tissue on MRI.

Leithner D, Baltzer PA, Magometschnigg HF, Wengert GJ, Karanikas G, Helbich TH, Weber M, Wadsak W, Pinker K. Leithner D, et al. J Nucl Med. 2016 Oct;57(10):1518-1522. doi: 10.2967/jnumed.116.174904. Epub 2016 May 26. J Nucl Med. 2016. PMID: 27230924 Free article. Clinical Trial.

4

Preliminary analysis: Background parenchymal 18F-FDG uptake in breast cancer patients appears to correlate with background parenchymal enhancement and to vary by distance from the index cancer.

Kim E, Mema E, Axelrod D, Sigmund E, Kim SG, Babb J, Melsaether AN. Kim E, et al. Eur J Radiol. 2019 Jan;110:163-168. doi: 10.1016/j.ejrad.2018.11.031. Epub 2018 Nov 28. Eur J Radiol. 2019. PMID: 30599855 Free PMC article.

5

Does breast MRI background parenchymal enhancement indicate metabolic activity? Qualitative and 3D quantitative computer imaging analysis.

Mema E, Mango VL, Guo X, Karcich J, Yeh R, Wynn RT, Zhao B, Ha RS. Mema E, et al. J Magn Reson Imaging. 2018 Mar;47(3):753-759. doi: 10.1002/jmri.25798. Epub 2017 Jun 24. J Magn Reson Imaging. 2018. PMID: 28646614

6

Improved differentiation of benign and malignant breast tumors with multiparametric 18fluorodeoxyglucose positron emission tomography magnetic resonance imaging: a feasibility study.

Pinker K, Bogner W, Baltzer P, Karanikas G, Magometschnigg H, Brader P, Gruber S, Bickel H, Dubsky P, Bago-Horvath Z, Bartsch R, Weber M, Trattnig S, Helbich TH. Pinker K, et al. Clin Cancer Res. 2014 Jul 1;20(13):3540-9. doi: 10.1158/1078-0432.CCR-13-2810. Clin Cancer Res. 2014. PMID: 24963052

7

Diagnostic accuracy of (18)F-FDG PET/CT compared with that of contrast-enhanced MRI of the breast at 3 T.

Magometschnigg HF, Baltzer PA, Fueger B, Helbich TH, Karanikas G, Dubsky P, Rudas M, Weber M, Pinker K. Magometschnigg HF, et al. Eur J Nucl Med Mol Imaging. 2015 Oct;42(11):1656-1665. doi: 10.1007/s00259-015-3099-1. Epub 2015 Jun 30. Eur J Nucl Med Mol Imaging. 2015. PMID: 26121928 Clinical Trial.

8

Apparent diffusion coefficient mapping using diffusion-weighted MRI: impact of background parenchymal enhancement, amount of fibroglandular tissue and menopausal status on breast cancer diagnosis.

Horvat JV, Durando M, Milans S, Patil S, Massler J, Gibbons G, Giri D, Pinker K, Morris EA, Thakur SB. Horvat JV, et al. Eur Radiol. 2018 Jun;28(6):2516-2524. doi: 10.1007/s00330-017-5202-4. Epub 2018 Jan 12. Eur Radiol. 2018. PMID: 29330631 Free PMC article.

9

Metabolic changes in breast cancer on dual-time-point ¹⁸F-FDG PET/CT imaging according to primary tumor uptake and background parenchymal enhancement.

Kim HO, Kim BS, Kang SY, Bang JI, An J, Kim JH, Yoon HJ. Kim HO, et al. Ann Nucl Med. 2020 Dec;34(12):942-951. doi: 10.1007/s12149-020-01525-z. Epub 2020 Sep 24. Ann Nucl Med. 2020. PMID: 32974848

10

Background ¹⁸F-FDG uptake in positron emission mammography (PEM): correlation with mammographic density and background parenchymal enhancement in breast MRI.

Koo HR, Moon WK, Chun IK, Eo JS, Jeyanth JX, Chang JM, Cho N, Kang KW. Koo HR, et al. Eur J Radiol. 2013 Oct;82(10):1738-42. doi: 10.1016/j.ejrad.2013.05.016. Epub 2013 Jun 24. Eur J Radiol. 2013. PMID: 23806533 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

299 results

Results by year